Ligand Pharmaceuticals Newsroom

Craig-Hallum Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating

Moomoo NewsSep 26 09:31 ET

Ligand Pharmaceuticals Price Target Raised to $110.00/Share From $95.00 by Benchmark

Dow JonesAug 12 13:03 ET

Ligand Pharmaceuticals Analyst Ratings

BenzingaAug 12 12:29 ET

Ligand Pharmaceuticals Price Target Maintained With a $130.00/Share by RBC Capital

Dow JonesAug 7 13:23 ET

Ligand Pharmaceuticals Analyst Ratings

BenzingaAug 7 13:15 ET

RBC Capital Reiterates Outperform on Ligand Pharmaceuticals, Maintains $130 Price Target

BenzingaAug 7 13:14 ET

Craig-Hallum Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating

Moomoo NewsAug 6 09:33 ET

Barclays Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $110

Moomoo NewsAug 6 06:31 ET

Craig-Hallum Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating

Moomoo NewsAug 5 09:33 ET

Ligand Pharmaceuticals Analyst Ratings

BenzingaJul 30 06:05 ET

RBC Capital Initiates Ligand Pharmaceuticals(LGND.US) With Buy Rating, Announces Target Price $130

Moomoo NewsJul 30 05:34 ET

Barclays Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $110

Moomoo NewsJul 25 05:31 ET

Craig-Hallum Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating

Moomoo NewsJul 24 09:39 ET

Ligand Pharmaceuticals Analyst Ratings

BenzingaJul 8 13:57 ET

What 4 Analyst Ratings Have To Say About Ligand Pharmaceuticals

BenzingaJun 28 15:02 ET

Benchmark Reiterates Buy on Ligand Pharmaceuticals, Maintains $95 Price Target

BenzingaJun 28 10:15 ET

Ligand Pharmaceuticals Analyst Ratings

BenzingaJun 27 11:47 ET

Ligand Pharmaceuticals Analyst Ratings

BenzingaMay 8 06:34 ET

HC Wainwright & Co. Reiterates Buy on Ligand Pharmaceuticals, Maintains $144 Price Target

BenzingaMay 8 06:34 ET

Ligand Pharmaceuticals Analyst Ratings

BenzingaApr 12 09:14 ET